BALTICLINIC OFFICIAL, MB - financials and debts

Company age: 3 y. 2 mo.

Update

BALTICLINIC OFFICIAL - Company finances

EUR
2023
From: 2023-07-11
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 29,310 38,740 44,629
Profit before tax 21,533 24,411 28,458
Net profit 21,533 23,190 26,751
Equity 21,633 28,604 11,255
Liabilities 26,883 830 0
Non-current assets 28,883 0 0
Current assets 19,633 29,434 11,255
Total assets 48,516 29,434 11,255
Taxes paid
STI taxes - - 2,540
Financial indicators
Revenue change y/y - +32.2% +15.2%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 44.4% 78.8% 237.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 99.5% 81.1% 237.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 73.5% 59.9% 59.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 73.5% 63.0% 63.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.2 0.0 -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

BALTICLINIC OFFICIAL - Social security debts

The company had no debts to Sodra

BALTICLINIC OFFICIAL - VMI tax arrears

From To Overdue, €
2026-03-20 2026-05-26 3.93
2026-03-11 2026-03-19 0.33
2025-06-19 2026-03-10 3.93
2025-06-18 2025-06-18 3.6
2025-06-02 2025-06-10 1447.0
2025-05-31 2025-06-01 1435.84

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
BALTICLINIC OFFICIAL, MB (code 306354471) is a small partnership engaged in general medical practice activities. In 2025, the company generated revenue of €44.6K and net profit of €26.8K, with a profit margin of 59.9%. Revenue increased by 15.2% year on year and by 52.3% over two years, showing a steady upward trajectory from €29.3K in 2023 to €38.7K in 2024 and €44.6K in 2025. Net profit also rose from €21.5K in 2023 to €23.2K in 2024 and €26.8K in 2025. The balance sheet was modest in 2025, with total assets and equity both at €11.3K. Asset turnover stood at 3.97x, indicating that the company generated substantial revenue relative to its asset base. Profitability remained strong throughout the period, although the very high return metrics reflect a small equity base.